|
CXORF40B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.993700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.48130000002345E-06 |
| Normal-vs-Stage2 |
1.050590E-01 |
| Normal-vs-Stage3 |
5.820000E-01 |
| Normal-vs-Stage4 |
4.22789999999784E-05 |
| Stage1-vs-Stage2 |
5.122400E-01 |
| Stage1-vs-Stage3 |
2.187600E-02 |
| Stage1-vs-Stage4 |
6.805700E-02 |
| Stage2-vs-Stage3 |
2.998800E-01 |
| Stage2-vs-Stage4 |
7.929600E-02 |
| Stage3-vs-Stage4 |
1.393990E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.994200E-04 |
| Normal-vs-AfricanAmerican |
1.524660E-03 |
| Normal-vs-Asian |
4.576400E-01 |
| Caucasian-vs-AfricanAmerican |
9.553800E-01 |
| Caucasian-vs-Asian |
3.437400E-01 |
| AfricanAmerican-vs-Asian |
3.735400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55000000001682E-06 |
| Normal-vs-Female |
2.475800E-01 |
| Male-vs-Female |
3.592500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.101200E-03 |
| Normal-vs-Extreme_Weight |
1.99428999999585E-05 |
| Normal-vs-Obese |
1.236360E-02 |
| Normal-vs-Extreme_Obese |
1.902990E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.392800E-01 |
| Normal_Weight-vs-Obese |
4.442800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.533400E-01 |
| Extreme_Weight-vs-Obese |
6.906500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.540800E-01 |
| Obese-vs-Extreme_Obese |
2.305800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.347900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.560700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.195270E-04 |
| Normal-vs-Age(81-100Yrs) |
1.016870E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.014200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.888780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.552300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.406100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.204230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.099000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.95342000000043E-05 |
| Normal-VS-Type2 PRCC |
3.117500E-03 |
| Normal-VS-KIRP CIMP |
2.175900E-02 |
| Normal-VS-Unclassified PRCC |
4.274300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.948600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.929400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.425210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.270600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.117400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.068400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.896250E-03 |
| Normal-vs-N1 |
4.316900E-03 |
| Normal-vs-N2 |
1.075620E-01 |
| N0-vs-N1 |
8.438800E-01 |
| N0-vs-N2 |
9.699600E-01 |
| N1-vs-N2 |
9.547000E-01 |
|
|
